{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T07:00:56Z","timestamp":1771225256524,"version":"3.50.1"},"reference-count":23,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Cathet Cardio Intervent"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>The recent voluntary withdrawal of the ACURATE neo2 transcatheter aortic valve replacement device by Boston Scientific offers a compelling case study in the complex interplay of device design, clinical evidence, regulatory requirements, and market dynamics in modern structural heart interventions. Despite promising performance in European and Canadian registries, the ACURATE neo2 valve failed to demonstrate non\u2010inferiority compared with commercially available balloon\u2010expandable and self\u2010expanding platforms in the pivotal ACURATE IDE randomized controlled trial. These results, coupled with introduction of a new regulatory requirements by the European notified body ultimately led to the global discontinuation of the platform. This review critically examines the technological characteristics of ACURATE neo2, compares it with other leading TAVR devices, and explores the potential reasons\u2014ranging from clinical to strategic\u2014that may have led to its market exit. Emphasis is placed on the role of randomized trials in assessing new structural therapies, including a discussion of methodological challenges and opportunities for adaptive trial designs. A structured comparison of device features and withdrawal rationales is also provided, highlighting lessons relevant to clinicians, regulators, and industry stakeholders. Ultimately, the ACURATE neo2 experience underscores the need for robust validation strategies, procedural standardization, and adaptive development pathways in a saturated and high\u2010stakes market. Lessons learned from this platform should inform future innovation in TAVR and broader cardiovascular device development.<\/jats:p>","DOI":"10.1002\/ccd.70092","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T13:15:24Z","timestamp":1755522924000},"page":"2554-2560","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lessons Learned From the ACURATE IDE Trial for Transcatheter Aortic Valve Replacement"],"prefix":"10.1002","volume":"106","author":[{"given":"Arturo","family":"Giordano","sequence":"first","affiliation":[{"name":"Unit\u00e0 Operativa di Interventistica Cardiovascolare, Pineta Grande Hospital Castel Volturno Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6103-8510","authenticated-orcid":false,"given":"Giuseppe","family":"Biondi\u2010Zoccai","sequence":"additional","affiliation":[{"name":"Department of Medical\u2010Surgical Sciences and Biotechnologies Sapienza University of Rome Latina Italy"},{"name":"Maria Cecilia Hospital, GVM Care &amp; Research Cotignola Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9163-724X","authenticated-orcid":false,"given":"David J.","family":"Cohen","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Foundation New York New York USA"},{"name":"St. Francis Hospital Roslyn New York USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo","family":"Bagur","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine London Health Sciences Centre Western University London Ontario Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Corcione","sequence":"additional","affiliation":[{"name":"Unit\u00e0 Operativa di Interventistica Cardiovascolare, Pineta Grande Hospital Castel Volturno Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2025,8,18]]},"reference":[{"key":"e_1_2_14_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-05912-5"},{"key":"e_1_2_14_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.26802"},{"key":"e_1_2_14_4_1","doi-asserted-by":"publisher","DOI":"10.1080\/17434440.2018.1526675"},{"key":"e_1_2_14_5_1","doi-asserted-by":"publisher","DOI":"10.17925\/HI.2021.15.1.37"},{"key":"e_1_2_14_6_1","doi-asserted-by":"publisher","DOI":"10.4244\/EIJ-D-24-00514"},{"key":"e_1_2_14_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2024.07.005"},{"key":"e_1_2_14_8_1","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.029464"},{"key":"e_1_2_14_9_1","doi-asserted-by":"publisher","DOI":"10.4244\/EIJ-D-22-00289"},{"key":"e_1_2_14_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.carrev.2022.07.010"},{"key":"e_1_2_14_11_1","unstructured":"Boston Scientific: The ACURATE Aortic Valve Platform accessed June 11 2025 https:\/\/www.bostonscientific.com\/en-US\/medical-specialties\/structural-heart\/acurate-ide-trial\/acurate-neo2-for-physicians.html."},{"key":"e_1_2_14_12_1","doi-asserted-by":"publisher","DOI":"10.4244\/EIJ-D-22-00914"},{"key":"e_1_2_14_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-020-01364-4"},{"key":"e_1_2_14_14_1","doi-asserted-by":"publisher","DOI":"10.23736\/S0026-4725.18.04707-2"},{"key":"e_1_2_14_15_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13226857"},{"key":"e_1_2_14_16_1","doi-asserted-by":"publisher","DOI":"10.17925\/HI.2024.18.1.4"},{"key":"e_1_2_14_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2018.11.036"},{"key":"e_1_2_14_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(25)00319-8"},{"key":"e_1_2_14_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2025.05.011"},{"key":"e_1_2_14_20_1","unstructured":"MassDevice: Boston Scientific Discontinues Acurate TAVR Sales Cites Regulatory Burden accessed June 10 2025 https:\/\/www.massdevice.com\/boston-scientific-discontinues-acurate-tavr-sales-cites-regulatory-burden\/."},{"key":"e_1_2_14_21_1","doi-asserted-by":"publisher","DOI":"10.2459\/JCM.0000000000000489"},{"key":"e_1_2_14_22_1","unstructured":"Reuters: Boston Scientific to Stop Heart Device Sales Amid Regulatory Challenges accessed June 10 2025 https:\/\/www.reuters.com\/business\/healthcare-pharmaceuticals\/boston-scientific-not-seek-us-approval-heart-device-amid-regulatory-challenges-2025-05-28\/."},{"key":"e_1_2_14_23_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.120.010440"},{"key":"e_1_2_14_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-031-52565-0"}],"container-title":["Catheterization and Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ccd.70092","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ccd.70092","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ccd.70092","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T06:01:22Z","timestamp":1771221682000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ccd.70092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,18]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10.1002\/ccd.70092"],"URL":"https:\/\/doi.org\/10.1002\/ccd.70092","archive":["Portico"],"relation":{},"ISSN":["1522-1946","1522-726X"],"issn-type":[{"value":"1522-1946","type":"print"},{"value":"1522-726X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,18]]},"assertion":[{"value":"2025-06-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}